Outcomes of retreatment with anti-PD-1 monotherapy after response to first course in patients with cutaneous melanoma.
Future Oncol
; 16(20): 1441-1453, 2020 Jul.
Article
in En
| MEDLINE
| ID: mdl-32410465
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Skin Neoplasms
/
Programmed Cell Death 1 Receptor
/
Antineoplastic Agents, Immunological
/
Melanoma
Limits:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Future Oncol
Year:
2020
Document type:
Article
Country of publication: